RT Journal Article
SR Electronic
T1 Digital Nanofluidic Chip for Simple and Highly Quantitative Detection of HPV Target
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.01.24303620
DO 10.1101/2024.03.01.24303620
A1 Liu, Li
A1 Dollery, Stephen J.
A1 Tobin, Gregory J.
A1 Lu, Guoyu
A1 Du, Ke
YR 2024
UL http://medrxiv.org/content/early/2024/03/02/2024.03.01.24303620.abstract
AB Quantitative analysis of human papillomavirus (HPV)-infected cervical cancer is essential for early diagnosis and timely treatment of cervical cancer. Here, we introduce a novel energy transfer-labeled oligonucleotide probe to enhance the loop-mediated isothermal amplification (LAMP) assay for highly sensitive and specific detection of HPV 16. Conducted as a single-step assay within a digital nanofluidic chip featuring numerous reaction reservoirs, our method facilitates target amplification under isothermal conditions. Targeting an HPV 16 gene, our chip demonstrates the capability to detect HPV DNA at concentrations as low as 1 fM, spanning a dynamic range of five orders of magnitude. Importantly, our digital chip allows for highly quantitative detection of target genes at low concentrations, with the correlation between target concentration and the number of microwells exhibiting fluorescence signals. Furthermore, we have developed a computer vision method for automated and 100% accurate quantification of target concentrations. This research holds promising applications in clinical diagnosis and is poised for seamless integration into both hospital and point-of-care settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH R35GM 142763 NIH 75N93023C00056-0-9999-1 USDA USDA NIFA 2022-67021-41478Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors